Skip to content

Navigating the Regulatory Landscape in Clinical Trials in 2024

21
Feb
Navigating the Regulatory Landscape in Clinical Trials in 2024

Staying current with regulatory changes is important when it comes to staying out of trouble with regulatory agencies, maintaining your reputation, and successfully conducting clinical trials. Join Marc Wartenberger, Director Corporate QA & Compliance at CRIO, for a review of new regulations, guidance, and decisions from 2023 that will impact clinical research. Highlights include:

  • New Part 11 guidance
  • FDA DCT guidance
  • FDA Patient Diversity guidance
  • EU-US Data Privacy Framework

The featured speaker will also provide insights into anticipated changes for 2024. Webinar participants will:

  • Review industry regulations and guidance on Decentralized Clinical Trials (DCT), Electronic Records & Signatures (Part 11), Patient Diversity, and EU-US Data Privacy Framework.
  • Formulate a plan to avoid regulatory repercussions by preparing for upcoming trial directives and changes that impact clinical research.
  • Identify strategies to prepare for regulatory changes by adapting your operations.

The webinar will include practical advice for how to stay compliant with real world examples from Marc’s experience. Join this webinar to explore pivotal regulatory updates affecting clinical research and proactive strategies.

Click here to learn more and to register.

Share this event
You may also find interesting
Explore our Events
8 -9
Oct
Clinical Outsourcing Group West Coast
San Francisco, CA
23 -24
Oct
Outsourcing in Clinical Trials New England 2024
Boston, MA
16 -17
Oct
Clinical Trials Strategic Summit
San Francisco, CA

Get articles delivered to your inbox, every week